Corpus ID: 13241128

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome.

  title={The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome.},
  author={Yu O Timovska and V. M. Pivnyuk and Igor N. Todor and Nikolay Anikusko and V Chekhun},
  journal={Experimental oncology},
  volume={33 3},
The incidence of breast cancer has been increasing recently worldwide. Therefore, the search for the novel techniques for diagnosis and treatment as well as the studies elucidating pathogenetic mechanisms associated with tumorogenesis and delineating the molecular markers useful for diagnostics and monitoring of the disease are the topical issues of the day. The tumor develops in the setting of the metabolic disorders. In particular, tumor growth is accompanied by the impaired lipid metabolism… Expand
Evaluation of Serum Lipids and C-peptide among Breast Cancer Patients with Chemotherapy
Altered serum lipid parameters and C-peptide indicated the risk of cardiovascular diseases and diabetes in cancer patients and Routine assessments of these parameters are necessary for follow up care during breast cancer management. Expand
Atypical plasma lipid profile in cancer patients: cause or consequence?
The present review highlights and compiles findings from different research groups regarding association of plasma lipoprotein levels with the risk of developing various types of cancer. Expand
A case-control study of the lipid profile of women with breast cancer
Community and oncology nurses, having considerable knowledge about health and lifestyle of their patients, should be more involved in basic education to decrease cancer risk, especially by women with alarming LDL-C level. Expand
Significance of the plasma lipid profile in cases of carcinoma of cervix: a tertiary hospital based study.
The study showed TG is elevated in cervical cancer, and that TC and LDL-C are proportional to the spread of cancer as it increases from stage I to stage IV. Expand
Chapter 4 Cancer Associated Dyslipidemia
Dyslipidemia in cancer patients is reported to be linked with cancer risk and progression of the disease. Previous research findings showed that low levels of serum cholesterol and elevated levels ofExpand
Rosiglitazone shows partial oncostatic effect in rat mammary carcinogenesis.
Higher rosiglitazone dose alleviated some metabolic alterations resulting from cancer progression more effectively but induced a prominent cardiac hypertrophy. Expand
One-Cell Analysis as a Technique for True Single-Cell Analysis of Organelles in Breast Tumor and Adjacent Normal Tissue to Profile Fatty Acid Composition of Triglyceride Species
Breast cancer develops in an adipose rich environment of normal adipocytes that are known to aid in tumor progression through an unknown method of lipid transfer from normal cells to tumor cells.Expand


The metabolic syndrome: A high-risk state for cancer?
It is proposed that the metabolic syndrome be considered as a high-risk state for certain types of cancer and that this relationship should be systematically explored across cancer types. Expand
Metabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project
The metabolic syndrome was associated with a decreased risk of incident breast cancer in women below age 50 with high body mass index, and with an increased risk of breast cancer mortality in women above 60. Expand
Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer
The alterations in lipid profile levels showed a significant correlation with breast cancer risk, disease status, and treatment outcome. Expand
Metabolic syndrome and endometrial carcinoma.
The association between the metabolic syndrome and endometrial carcinoma risk seems to go beyond the risk conferred by obesity alone, particularly in women with a high body mass index. Expand
Serum lipid profile of breast cancer patients.
The association between dyslipidaemia, BMI and increased breast cancer risk is confirmed and the lipid profile generally increased with age in both subjects and controls with the subjects having a much higher value than the corresponding control. Expand
Obesity, metabolic syndrome, and prostate cancer.
Whether obesity and metabolic syndrome modulate the risk of prostate cancer through chronic inflammation needs to be investigated further. Expand
Serum lipids and tissue DNA content in Egyptian female breast cancer patients.
An association between high levels of serum, total lipid and total cholesterol, and increased breast cancer risk in premenopausal women is suggested and also suggested for the high total serum lipid and triglyceride levels in post menopausal women. Expand
Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women
No association between breast cancer risk and blood lipids was found in the total population, nor when the data were divided into those diagnosed before or after the age of 50 as a dividing line between pre- and postmenopausal diagnosis. Expand
Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project
Peri/postmenopausal women had a significantly increased age‐adjusted relative risk of breast cancer associated with height, and the RR was increased over quartiles of cholesterol levels, and no other significant associations were found. Expand
Metabolic syndrome and breast cancer in the Me-Can (Metabolic Syndrome and Cancer) project. Cancer Epidemiology, Biomarkers
  • Prevention
  • 2010